Molecular Partners AG (SIX:MOLN)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - MOLN

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - MOLN

  • Market CapCHF0.000m
  • SymbolSIX:MOLN
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINCH0256379097

Company Profile

Molecular Partners AG is a clinical-stage biopharmaceutical company. The company focuses on the discovery, development and prospective commercialization of a new class of biopharmaceutical products. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.Molecular Partners AG is a biopharmaceutical company. The company is engaged in the discovery, development and commercialization of DARPins a novel class of therapeutic proteins.

Latest MOLN news

Currently there for this company. Visit our news hub for other news .